COMP <GO>
TCMD vs MDXG // ALTMAN Z-SCORE & DEBT/EQUITY
Tactile Systems Technology Inc. (NASDAQ) VS. MiMedx Group Inc (NASDAQ) • 15-METRIC TALLY: TCMD 2
— MDXG 10
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: TCMD
LAST: $23.04 (-5.22%) • MKT CAP: $550.7M
balance-sheet
8.38
LAST: $3.88 (-2.27%) • MKT CAP: $579.3M
balance-sheet
6.45
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TCMD VS. MDXG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TCMD | MDXG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 75.90% | 82.60% | -6.70 | MDXG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 17.10% | 47.20% | -30.10 | MDXG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 14.9x | 6.7x | +8.20 | MDXG | /valuation <GO> |
| Free Cash Flow Yield | 7.34% | 12.77% | -5.43 | MDXG | /fcf-yield <GO> |
| Operating Margin | 8.90% | 15.30% | -6.40 | MDXG | /operating-margins <GO> |
| Net Profit Margin | 5.80% | 11.60% | -5.80 | MDXG | /net-margins <GO> |
| Revenue Growth (YoY) | 12.50% | 20.00% | -7.50 | MDXG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 8.38 | 6.45 | +1.93 | TCMD | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 9/9 | -1.00 | MDXG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 59.2 | 37.7 | +21.50 | TCMD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 24.3x | 10.0x | +14.30 | MDXG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $550.7M | $579.3M | -$28.6M | MDXG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TCMD REV | MDXG REV | TCMD GROSS % | MDXG GROSS % | TCMD FCF | MDXG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $329.5M | $418.6M | 75.9% | 82.6% | $40.4M | $74.0M |
| FY 2024 | $293.0M | $348.9M | 74.0% | 82.8% | $38.3M | $66.2M |
| FY 2023 | $274.4M | $321.5M | — | — | $35.9M | $26.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TCMD // BETA —
MDXG // BETA —